ATE175119T1 - Vakzine gegen immunodefizienz-virus der katze (kiv) - Google Patents

Vakzine gegen immunodefizienz-virus der katze (kiv)

Info

Publication number: ATE175119T1
Authority: AT; Austria
Prior art keywords: kiv; immunodeficiency virus; vaccine against; against cat; cat immunodeficiency
Prior art date: 1992-09-21

Application number

AT93920971T

Other languages

English (en)

Inventor

Michael James Francis

Original Assignee

Mallinckrodt Veterinary Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-09-21

Filing date

1993-09-20

Publication date

1999-01-15

1993-09-20 Application filed by Mallinckrodt Veterinary Inc filed Critical Mallinckrodt Veterinary Inc

1999-01-15 Application granted granted Critical

1999-01-15 Publication of ATE175119T1 publication Critical patent/ATE175119T1/de

Links

229960005486 vaccine Drugs 0.000 title abstract 2
206010061598 Immunodeficiency Diseases 0.000 title 1
208000029462 Immunodeficiency disease Diseases 0.000 title 1
241000700605 Viruses Species 0.000 title 1
230000007813 immunodeficiency Effects 0.000 title 1
229920001184 polypeptide Polymers 0.000 abstract 2
102000004196 processed proteins & peptides Human genes 0.000 abstract 2
108090000765 processed proteins & peptides Proteins 0.000 abstract 2
125000003275 alpha amino acid group Chemical group 0.000 abstract 1
230000000890 antigenic effect Effects 0.000 abstract 1
239000012634 fragment Substances 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
102000039446 nucleic acids Human genes 0.000 abstract 1
108020004707 nucleic acids Proteins 0.000 abstract 1
150000007523 nucleic acids Chemical class 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Gastroenterology & Hepatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AT93920971T 1992-09-21 1993-09-20 Vakzine gegen immunodefizienz-virus der katze (kiv) ATE175119T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB929219936A GB9219936D0 (en)	1992-09-21	1992-09-21	Vaccines

Publications (1)

Publication Number	Publication Date
ATE175119T1 true ATE175119T1 (de)	1999-01-15

Family

ID=10722245

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93920971T ATE175119T1 (de)	1992-09-21	1993-09-20	Vakzine gegen immunodefizienz-virus der katze (kiv)

Country Status (11)

Country	Link
EP (1)	EP0661999B1 (de)
JP (1)	JP3604384B2 (de)
AT (1)	ATE175119T1 (de)
AU (1)	AU4826493A (de)
DE (1)	DE69322872T2 (de)
DK (1)	DK0661999T3 (de)
ES (1)	ES2127294T3 (de)
GB (1)	GB9219936D0 (de)
GR (1)	GR3029264T3 (de)
WO (1)	WO1994006471A1 (de)
ZA (1)	ZA936970B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2234995A (en) *	1994-04-29	1995-11-29	Pharmacia & Upjohn Company	Feline immunodeficiency virus vaccine
IT1276509B1 (it) *	1995-03-31	1997-10-31	Istituto Superiore Della Sanit	Vaccino per la profilassiimmunitaria dell'infezione da virus della immunodeficienza felina del gatto domestico.
US6300118B1 (en)	1995-06-07	2001-10-09	American Home Products Corporation	Plasmids comprising a genetically altered feline immunodeficiency virus genome
US5820869A (en) *	1995-06-07	1998-10-13	American Home Products Corporation	Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
US5849303A (en) *	1995-06-07	1998-12-15	American Home Products Corporation	Recombinant feline Immunodeficiency virus subunit vaccines employing baculoviral-expressed envelope glycoproteins derived from isolate NCSU-1 and their use against feline immunodeficiency virus infection
AU728750B2 (en) *	1995-08-25	2001-01-18	Regents Of The University Of California, The	Multi-subtype FIV vaccines
FR2769916B1 (fr)	1997-10-17	2000-12-01	Centre Nat Rech Scient	Peptides issus du gene env du virus de l'immunodeficience feline et leurs applications immunoprotectrices et vaccinales
FR2771011B1 (fr)	1997-11-17	2000-01-28	Hippocampe	Obtention de vaccins destines a prevenir les effets pathogenes associes a une infection retrovirale
GB9827077D0 (en)	1998-12-09	1999-02-03	Expro North Sea Ltd	Improvements in or relating to well fluid sampling
EP1203078B1 (de) *	1999-07-08	2005-05-04	Mologen Forschungs-, Entwicklungs- und Vertriebs GmbH	Impfstoff gegen infektionen mit lentiviren, wie dem felinen immunschwäche-virus der katze
FR2828686B1 (fr) *	2001-08-17	2003-12-12	Hippocampe	Nouveaux peptides et leur utilisation comme medicaments contre l'infection par le fiv chez le chat
FR2828687B1 (fr) *	2001-08-17	2003-12-12	Hippocampe	Nouveaux peptides et leur utilisation comme medicaments contre l'infection par le fiv chez le chat
US7201903B2 (en)	2003-09-11	2007-04-10	Idexx Laboratories, Inc.	Method and device for detecting feline immunodeficiency virus
WO2005062053A2 (en)	2003-12-18	2005-07-07	Idexx Laboratories, Inc.	Method and device for detecting feline immunodeficiency virus
WO2005080939A2 (en) *	2004-02-19	2005-09-01	Idexx Laboratories, Inc.	Method and device for detecting feline immunodeficiency virus
CA2576902C (en)	2004-06-30	2012-05-08	Idexx Laboratories, Inc.	Method and device for detecting feline immunodeficiency virus
EP1761556A1 (de)	2004-06-30	2007-03-14	Idexx Laboratories, Inc.	Verfahren und vorrichtung zum nachweis des katzen-immunschwäche-virus (fiv) umfassend die verwendung von peptiden, die von der v3-region des fiv-env-proteins abgeleitet sind
US7291338B2 (en)	2005-03-09	2007-11-06	Idexx Laboratories, Inc.	Method and device for detecting feline immunodeficiency virus
EP2553452B1 (de)	2010-04-02	2015-03-04	IDEXX Laboratories, Inc.	Nachweis des felinen immundefizienzvirus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2669338A1 (fr) *	1990-11-21	1992-05-22	Centre Nat Rech Scient	Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline.
US6228608B1 (en) *	1991-02-28	2001-05-08	Aquila Biopharmaceuticals, Inc.	Recombinant FIV glycoprotein 160 and P24 gag protein
AU667669B2 (en) *	1991-06-14	1996-04-04	Idexx Laboratories, Inc.	Detection of mammalian immunodeficiency viruses
WO1993001304A1 (en) *	1991-07-10	1993-01-21	Synbiotics Corporation	Synthetic peptides related to fiv-env proteins

1992
- 1992-09-21 GB GB929219936A patent/GB9219936D0/en active Pending
1993
- 1993-09-20 DK DK93920971T patent/DK0661999T3/da active
- 1993-09-20 AU AU48264/93A patent/AU4826493A/en not_active Abandoned
- 1993-09-20 WO PCT/GB1993/001974 patent/WO1994006471A1/en not_active Ceased
- 1993-09-20 AT AT93920971T patent/ATE175119T1/de not_active IP Right Cessation
- 1993-09-20 ES ES93920971T patent/ES2127294T3/es not_active Expired - Lifetime
- 1993-09-20 JP JP50793594A patent/JP3604384B2/ja not_active Expired - Fee Related
- 1993-09-20 DE DE69322872T patent/DE69322872T2/de not_active Expired - Lifetime
- 1993-09-20 EP EP93920971A patent/EP0661999B1/de not_active Expired - Lifetime
- 1993-09-21 ZA ZA936970A patent/ZA936970B/xx unknown
1999
- 1999-02-01 GR GR990400341T patent/GR3029264T3/el unknown

Also Published As

Publication number	Publication date
JPH08504090A (ja)	1996-05-07
ES2127294T3 (es)	1999-04-16
DE69322872T2 (de)	1999-05-27
EP0661999B1 (de)	1998-12-30
WO1994006471A1 (en)	1994-03-31
ZA936970B (en)	1994-08-29
JP3604384B2 (ja)	2004-12-22
DK0661999T3 (da)	1999-08-30
GR3029264T3 (en)	1999-05-28
GB9219936D0 (en)	1992-11-04
DE69322872D1 (de)	1999-02-11
EP0661999A1 (de)	1995-07-12
AU4826493A (en)	1994-04-12

Similar Documents

Publication	Publication Date	Title
DE69322872D1 (de)	1999-02-11	Vakzine gegen immunodefizienz-virus der katze (kiv)
DE69636487D1 (de)	2006-10-05	Zusammensetzungen zur Immuntherapie und Diagnose von Tuberculosis
HUP9901186A2 (hu)	1999-07-28	Peptid-és adjuvánsalapú gyógyszerkészítmény immunmodulációra
RU95115239A (ru)	1997-03-27	Аналог эритропоэтина
ATE141946T1 (de)	1996-09-15	Hiv-2-virusvarianten
NO912825L (no)	1992-01-20	Fremgangsmaate for fremstilling av kokonjugatvaksiner omfattende im munogent protein, hiv-beslektede peptider og anioniske grupper.
ES2144399T3 (es)	2000-06-16	Clonado del adn de virus de anemia de los pollos.
HUP9901688A2 (hu)	1999-09-28	A diabétesz kezelésére szolgáló, humán hősokk protein 60-ból származó új peptidek, készítmények, eljárások és kitek
DK610888A (da)	1988-11-02	Cardiodilatinfragmentet, fremgangsmaade til fremstilling deraf samt dets anvendelse
SE9101838D0 (sv)	1991-06-14	Novel peptides and their use
RU96116005A (ru)	1998-11-20	Штамм hominis immunodeficiti virus (hiv-i) вич-i/россия/гм-12-95 (ru1295) субтипа в для диагностических и вакцинных препаратов
NO922421L (no)	1992-08-20	Collagenbindende protein, samt fremstilling derav
IT1249684B (it)	1995-03-09	Epitopi della proteina env del virus dell'epatite c.
BR0114977A (pt)	2006-05-09	segmentos preferidos de proteìna de filamento neural e métodos para uso dos mesmos
ATE154244T1 (de)	1997-06-15	Induzierung eines schutzes gegen virale infektionen
ATE134878T1 (de)	1996-03-15	Impfstoffe gegen metazoen-parasiten
DK0732339T3 (da)	2002-08-19	Peptider fra HIV-gag-proteinet, fremstilling og anvendelse deraf
CA2143187A1 (en)	1994-03-31	Anti-feline immunodeficiency virus (fiv) vaccines
DE69434151D1 (de)	2004-12-30	Therapeutische inhaltsstoffe
AU4712993A (en)	1994-03-03	New peptides, antibodies raised against peptides and means for blocking said antibodies, application as medicaments, pharmaceutical compositions and utilization methods
ES2059801T3 (es)	1994-11-16	Nuevas linfoquinas, secuencias de adn que codifican para estas linfoquinas, y composiciones farmaceuticas conteniendo estas linfoquinas.
ATE174963T1 (de)	1999-01-15	Klonierung und expression eines rhoptry- assoziierten proteins aus p. falciparum
FI902814A0 (fi)	1990-06-05	Proteiner, vaccin och nukleinsyror.
BR0016740A (pt)	2002-09-03	Antìgenos de esporozoìto de cryptosporidium
ATE234861T1 (de)	2003-04-15	Influenzaimpfstoff, der als sinergistischer zusatzmittel influenzavirusinnenkörper enthält

Legal Events

Date	Code	Title	Description
1999-11-15	UEP	Publication of translation of european patent specification
2011-06-15	REN	Ceased due to non-payment of the annual fee